Our approach to data is both quantitative and qualitative. We do not stop with compiling your safety data, we help make sense of it and help maintain the risk-benefit of your treatments.
For efficient and effective review of line listings, frequency tabulations and trend reports to establish the benefit-risk evaluation of your marketed drugs in Canada. To ensure compliance to regulatory requirements, we perform collective analysis of drug safety cases of your drug through periodic reporting and aggregate reports. Our work will help you take the necessary steps including regulatory documents update and notifying the Health authorities in a timely manner.